欢迎光临金融市场技术研究院
微信公众号
投资群
读书群
文章
文章
报告
图书
公募
私募
资讯
搜 索
上传文档
首页
文章
报告
图书
公募
私募
资讯
金融终端
您的当前位置：
首页
>
研究报告
>
外盘报告
> 预览报告
In-line 1H 2017 Results. Tissue paper remains a growth driver
报告类型：港股公司研究
页数：5
文件大小：602K
上传时间：2024-09-20
机构：中国银河国际证券
作者：Mark Po Wong Chi Man
90阅读
0收藏
0下载
下载PDF
所需积分：1
如何获取K积分
下载PDF
下载全文所需积分：1
网友评论
{{Creator}}
{{Body}}
{{$val.TimeAgo({Dtime})}}
[回复]
{{Creator}}
：
回复
{{BeQuote}}
{{Body}}
{{$val.TimeAgo({Dtime})}}
[回复]
上传用户
文章
0
报告
0
图书
0
相关报告
Hong Kong NDR takeaways
Buy: 2Q17 beat on margin and construction business
A mixed picture of future growth and near term margin pressure; Hold
Revitalizing in 2H 2017
1H 2017 Results remains solid. Maintain BUY
Insulin slowed down, 6-APA positives reflected. Maintain HOLD.
Earnings improved but potential yet to be released: Maintain BUY
Virscend Education Interim Results
Concerns about Q2 results put to rest. Optics business development will trigger a further re-rating.
NEED MORE CONCRETE ACTION TO UNLOCK VALUE
{"InnerBanner":null,"MbPageUrl":"/m/Datums/Report?id=5763780","PageTitle":"In-line 1H 2017 Results. Tissue paper remains a growth driver-外盘报告 - 研究报告","Redirect":null,"Data":{"Uploader":{"ID":78,"Face":"/_files/face/0/lbod4mzl.jpg","UName":"伏岑","UpArts":0,"UpRpts":24027,"UpLbies":24},"Rid":5763780,"IsPdf":true,"IsExist":true,"PdfUrl":"/download2.mtachn.com/upload/report/外盘报告/20170822-中国银河国际证券-理文造纸-02314.HK-In-line1H2017Results.Tissuepaperremainsagrowthdriver.pdf","RePage":-1},"UserInfo":{"ID":0,"UName":null,"Face":null}}
微信公众号